Hypodermic Needles Market Size

  • Report ID: 4914
  • Published Date: Sep 11, 2025
  • Report Format: PDF, PPT

Hypodermic Needles Market Outlook:

Hypodermic Needles Market size was valued at USD 3.57 billion in 2025 and is set to exceed USD 6.51 billion by 2035, expanding at over 6.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of hypodermic needles is estimated at USD 3.77 billion.

The growth of the market can be attributed to the rising prevalence of chronic and infectious diseases such as Hepatitis B and Hepatitis C, along with the increasing number of diagnostic tests to treat such diseases. The Centers for Disease Control and Prevention estimates that 296 million people worldwide are infected with hepatitis B, while 58 million are infected with hepatitis C. According to the World Health Organization, global hepatitis C infections affect about 58 million people, and 1.5 million new infections occur each year. In addition, 1.5 million new cases of chronic hepatitis B are reported each year, with 296 million chronic hepatitis B infections in 2019. The increasing number of patients with chronic and infectious diseases has led to a surge in demand for hypodermic needles, as they are used to administer medications and vaccines to these patients. These needles are designed to deliver medication directly into the bloodstream, allowing for more efficient delivery of the medication and reducing the risk of infection.

In addition to these, factors that are believed to fuel the growth of hypodermic needles market include an increasing prevalence of chronic and Noncommunicable diseases (NCDs), a growing geriatric population, rising demand for injectable drugs, and increasing investments in healthcare infrastructure. The CDC reports that 6 out of 10 adults in the United States have at least one chronic disease. WHO estimates that NCDs account for 41 million deaths each year, representing 74% of all global deaths. With the rise in chronic NCDs, the need for medical treatments and procedures has also increased significantly. This has given rise to a higher demand for hypodermic needles market, as they are needed to administer medications and fluids to the patient.


Hypodermic Needles Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of hypodermic needles is estimated at USD 3.77 billion.

The global hypodermic needles market size crossed USD 3.57 billion in 2025 and is likely to expand at a CAGR of more than 6.2%, surpassing USD 6.51 billion revenue by 2035.

The North America hypodermic needles market is projected to capture a 37% share by 2035, attributed to rising chronic disease prevalence, an aging population, and technological advancements in hypodermic needles.

Key players in the market include Becton, Dickinson And Company, B. Braun Melsungen AG, Catalent Inc., Medtronic plc, Retractable Technologies, Inc., Smiths Group plc., Connecticut Hypodermics Inc., EXELINT International Co., MedPro Safety Products Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos